KRT5 and breast neoplasm: Eighty-six breast tumors and one normal breast sample from the UNC337 database, including 20 claudin-low tumors, were evaluated using dual immunofluorescence (IF) staining with epithelial (keratin 5/19) and mesenchymal (vimentin) markers.